Clinical Trials
82 trialsTesting the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
National Cancer Institute (NCI)
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
M.D. Anderson Cancer Center
Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
Baptist Health South Florida
RAINBO
Leiden University Medical Center
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer
City of Hope Medical Center
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Mayo Clinic
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Canadian Cancer Trials Group
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Alliance for Clinical Trials in Oncology
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NRG Oncology
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Canadian Cancer Trials Group
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Children's Oncology Group
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Children's Oncology Group
LAP100
NRG Oncology
MPN Childhood Registry
University of Erlangen-Nürnberg Medical School
The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
The First Affiliated Hospital of Soochow University
XAI-EGC
The First Affiliated Hospital of Soochow University
DIVINE
Mayo Clinic
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients
University of Michigan Rogel Cancer Center
Communication Issues in Patient and Provider Discussions of Immunotherapy
Emory University
EURACAN
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
Tempus AI
RESOLBE
Clinica Universidad de Navarra, Universidad de Navarra
Pediatric Normative Markerless Movement Analysis
MultiCare Health System Research Institute
An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
Fudan University
GU-01
University of Illinois at Chicago
EULAT
Centre Paul Strauss
An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Ohio State University Comprehensive Cancer Center
Estimating Jaw, Neck, and Shoulder Range of Motion Using an AI Model
National Taiwan University Hospital
The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota
Fudan University
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Mayo Clinic
Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis
Shanghai Tongji Hospital, Tongji University School of Medicine
GEMINI-NSCLC: NSCLC Biomarker Study
Tempus AI
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
SWOG Cancer Research Network
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
University of Michigan Rogel Cancer Center
TQ-BIRD
The University of Hong Kong-Shenzhen Hospital
Factors Affecting Wound Dehiscence in Pilonidal Sinus Surgery (ORIPIS)
Ankara Etlik City Hospital
Senolytics
Mayo Clinic
The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer
Fudan University
T-START-CR
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
RPx
Replimune, Inc.
SABR-SYNC
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
EURAGIL
Herlev Hospital
PROSa+
Technische Universität Dresden
MICROPAC
Herlev Hospital
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
RADIOSONIC
University Hospital, Lille
Molecular and Cellular Characterization of Skull Base Tumors
University of Pittsburgh